James Mulay Net Worth

What's James Mulay's mailing address?

James's mailing address filed with the SEC is 4978 Santa Anita Ave Suite 205, Temple City, CA 91780, USA.

Insiders trading at Fulgent Genetics Inc

Over the last 9 years, insiders at Fulgent Genetics Inc have traded over $32,817,108 worth of Fulgent Genetics Inc stock and bought 1,136,382 units worth $9,558,758 . The most active insiders traders include Hanlin Gao, Ming Hsieh a Paul Kim. On average, Fulgent Genetics Inc executives and independent directors trade stock every 28 days with the average trade being worth of $848,250. The most recent stock trade was executed by Paul Kim on 3 September 2024, trading 1,674 units of FLGT stock currently worth $36,761.

What does Fulgent Genetics Inc do?

mission developing flexible and affordable genetic testing that improves the everyday lives of those around us. founded in 2011, fulgent began with two simple ideas; flexibility and affordability. today, we strive to create the most effective and wide ranging tests on the market. all of this is done in the pursuit of bettering the everyday lives of our customers. we shine brightest when meaningful relationships, passion, and purpose come together. why fulgent? we are committed to working side-by-side with every one of our clients. this is essential to a strong and successful relationship and is our core way of doing business. we have collaborated with some of the top clinicians in our field who have assisted us in creating our panels, report formatting, and improvements to our website. our approach has always been simple: provide testing based on the specific needs of clinicians and their patients. customer support our support philosophy has always been simple: answer our client's ques

Fulgent Genetics Inc executives and stock owners

Fulgent Genetics Inc executives and other stock owners filed with the SEC include:

• Paul Kim,
  Chief Financial Officer
• Han Lin Gao,
  Chief Scientific Officer, Laboratory Director
• Paul Kim,
  Chief Financial Officer
• Ming Hsieh,
  Chairman, CEO & Pres
• Ming Hsieh,
  Chairman of the Board, President, Chief Executive Officer
• Jian Xie,
  Chief Operating Officer
• Dr. Han Lin Gao FACMG, M.D., Ph.D., D.A.B.M.G., F.A.C.M.G.,
  Chief Scientific Officer & Laboratory Director
• Linda Marsh,
  Independent Director
• John Bolger,
  Independent Director
• Yun Yen,
  Independent Director
• Nicole Borsje,
  IR Contact Officer
• Dr. Lawrence M. Weiss M.D.,
  Chief Medical Officer
• Brandon Perthuis,
  Chief Commercial Officer
• James Mulay,
  Director
• Long Usa, Inc. Xi,
  10% owner
• Genetics, Inc. Fulgent,
  Director
• Michael Nohaile,
  
• Regina E Groves,
  
• Jian Xie,
  President and COO
• Ming Ming Hsieh Trust Hsieh,
  Chief Executive Officer
• Leonard E Post,
  Director